ID   PAK3_HUMAN              Reviewed;         559 AA.
AC   O75914; A8K389; Q5JWX1; Q5JWX2; Q7Z2D6; Q7Z2E4; Q7Z3Z8; Q8WWK5;
AC   Q8WX23; Q9P0J8;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   10-MAY-2004, sequence version 2.
DT   02-NOV-2010, entry version 111.
DE   RecName: Full=Serine/threonine-protein kinase PAK 3;
DE            EC=2.7.11.1;
DE   AltName: Full=Beta-PAK;
DE   AltName: Full=Oligophrenin-3;
DE   AltName: Full=p21-activated kinase 3;
DE            Short=PAK-3;
GN   Name=PAK3; Synonyms=OPHN3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND DISEASE.
RX   MEDLINE=98400251; PubMed=9731525; DOI=10.1038/1675;
RA   Allen K.M., Gleeson J.G., Bagrodia S., Partington M.W.,
RA   Macmillan J.C., Cerione R.A., Mulley J.C., Walsh C.A.;
RT   "PAK3 mutation in nonsyndromic X-linked mental retardation.";
RL   Nat. Genet. 20:25-30(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Adrenal gland;
RA   Jiang C., Gu J., Fu S., Ren S., Gu Y., Huang Q., Dong H., Yu Y.,
RA   Fu G., Wang Y., Chen Z., Han Z.;
RT   "A novel gene expressed in the human adrenal gland.";
RL   Submitted (MAY-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   MEDLINE=22763540; PubMed=12777533; DOI=10.1093/molbev/msg134;
RA   Kitano T., Schwarz C., Nickel B., Paeaebo S.;
RT   "Gene diversity patterns at 10 X-chromosomal loci in humans and
RT   chimpanzees.";
RL   Mol. Biol. Evol. 20:1281-1289(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-535, AND MASS SPECTROMETRY.
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [9]
RP   VARIANT MRX30 CYS-67.
RX   PubMed=10946356;
RX   DOI=10.1002/1096-8628(20000814)93:4<294::AID-AJMG8>3.0.CO;2-F;
RA   Bienvenu T., des Portes V., McDonell N., Carrie A., Zemni R.,
RA   Couvert P., Ropers H.-H., Moraine C., van Bokhoven H., Fryns J.-P.,
RA   Allen K., Walsh C.A., Boue J., Kahn A., Chelly J., Beldjord C.;
RT   "Missense mutation in PAK3, R67C, causes X-linked nonspecific mental
RT   retardation.";
RL   Am. J. Med. Genet. 93:294-298(2000).
RN   [10]
RP   VARIANT MRX30 GLU-380.
RX   PubMed=12884430; DOI=10.1002/ajmg.a.20131;
RA   Gedeon A.K., Nelson J., Gecz J., Mulley J.C.;
RT   "X-linked mild non-syndromic mental retardation with neuropsychiatric
RT   problems and the missense mutation A365E in PAK3.";
RL   Am. J. Med. Genet. A 120:509-517(2003).
RN   [11]
RP   VARIANT [LARGE SCALE ANALYSIS] SER-440.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Key regulator of synapse formation and plasticity in the
CC       hippocampus (By similarity).
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium (By similarity).
CC   -!- ENZYME REGULATION: Activated by binding small G proteins. Binding
CC       of GTP-bound CDC42 or RAC1 to the autoregulatory region releases
CC       monomers from the autoinhibited dimer, enables phosphorylation of
CC       Thr-436 and allows the kinase domain to adopt an active structure
CC       (By similarity).
CC   -!- SUBUNIT: Interacts tightly with GTP-bound but not GDP-bound
CC       CDC42/p21 and RAC1. Shows highly specific binding to the SH3
CC       domains of phospholipase C-gamma and of adapter protein NCK.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O75914-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O75914-2; Sequence=VSP_010242;
CC   -!- TISSUE SPECIFICITY: Highly expressed in postmitotic neurons of the
CC       developing and postnatal cerebral cortex and hippocampus.
CC   -!- PTM: Autophosphorylated when activated by CDC42/p21.
CC   -!- DISEASE: Defects in PAK3 are the cause of mental retardation X-
CC       linked type 30 (MRX30) [MIM:300558]; also called X-linked mental
CC       retardation type 47 (MRX47). Mental retardation is a mental
CC       disorder characterized by significantly sub-average general
CC       intellectual functioning associated with impairments in adaptative
CC       behavior and manifested during the developmental period. Non-
CC       syndromic mental retardation patients do not manifest other
CC       clinical signs.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. STE20 subfamily.
CC   -!- SIMILARITY: Contains 1 CRIB domain.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- WEB RESOURCE: Name=GeneReviews;
CC       URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/PAK3";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF068864; AAC36097.1; -; mRNA.
DR   EMBL; AF155651; AAF67008.1; -; mRNA.
DR   EMBL; AB102659; BAC81128.1; -; mRNA.
DR   EMBL; AB102251; BAC80750.1; -; Genomic_DNA.
DR   EMBL; AB102252; BAC80751.1; -; Genomic_DNA.
DR   EMBL; AB102253; BAC80752.1; -; Genomic_DNA.
DR   EMBL; AB102254; BAC80753.1; -; Genomic_DNA.
DR   EMBL; AB102255; BAC80754.1; -; Genomic_DNA.
DR   EMBL; AB102256; BAC80755.1; -; Genomic_DNA.
DR   EMBL; AB102257; BAC80756.1; -; Genomic_DNA.
DR   EMBL; AB102258; BAC80757.1; -; Genomic_DNA.
DR   EMBL; AB102259; BAC80758.1; -; Genomic_DNA.
DR   EMBL; AB102260; BAC80759.1; -; Genomic_DNA.
DR   EMBL; AB102261; BAC80760.1; -; Genomic_DNA.
DR   EMBL; AB102262; BAC80761.1; -; Genomic_DNA.
DR   EMBL; AB102263; BAC80762.1; -; Genomic_DNA.
DR   EMBL; AB102264; BAC80763.1; -; Genomic_DNA.
DR   EMBL; AB102265; BAC80764.1; -; Genomic_DNA.
DR   EMBL; AB102266; BAC80765.1; -; Genomic_DNA.
DR   EMBL; AB102267; BAC80766.1; -; Genomic_DNA.
DR   EMBL; AB102268; BAC80767.1; -; Genomic_DNA.
DR   EMBL; AB102269; BAC80768.1; -; Genomic_DNA.
DR   EMBL; AB102270; BAC80769.1; -; Genomic_DNA.
DR   EMBL; AB102281; BAC80780.1; -; Genomic_DNA.
DR   EMBL; AB102282; BAC80781.1; -; Genomic_DNA.
DR   EMBL; AB102283; BAC80782.1; -; Genomic_DNA.
DR   EMBL; AB102284; BAC80783.1; -; Genomic_DNA.
DR   EMBL; AB102285; BAC80784.1; -; Genomic_DNA.
DR   EMBL; AB102286; BAC80785.1; -; Genomic_DNA.
DR   EMBL; AB102287; BAC80786.1; -; Genomic_DNA.
DR   EMBL; AB102288; BAC80787.1; -; Genomic_DNA.
DR   EMBL; AB102289; BAC80788.1; -; Genomic_DNA.
DR   EMBL; AB102290; BAC80789.1; -; Genomic_DNA.
DR   EMBL; AB102291; BAC80790.1; -; Genomic_DNA.
DR   EMBL; AB102292; BAC80791.1; -; Genomic_DNA.
DR   EMBL; AB102293; BAC80792.1; -; Genomic_DNA.
DR   EMBL; AB102294; BAC80793.1; -; Genomic_DNA.
DR   EMBL; AB102295; BAC80794.1; -; Genomic_DNA.
DR   EMBL; AB102296; BAC80795.1; -; Genomic_DNA.
DR   EMBL; AB102297; BAC80796.1; -; Genomic_DNA.
DR   EMBL; AB102298; BAC80797.1; -; Genomic_DNA.
DR   EMBL; AB102299; BAC80798.1; -; Genomic_DNA.
DR   EMBL; AB102300; BAC80799.1; -; Genomic_DNA.
DR   EMBL; AK290504; BAF83193.1; -; mRNA.
DR   EMBL; AL357774; CAI40843.1; -; Genomic_DNA.
DR   EMBL; AL031117; CAI40843.1; JOINED; Genomic_DNA.
DR   EMBL; AL117326; CAI40843.1; JOINED; Genomic_DNA.
DR   EMBL; AL357774; CAI40844.1; -; Genomic_DNA.
DR   EMBL; AL031117; CAI40844.1; JOINED; Genomic_DNA.
DR   EMBL; AL117326; CAI40844.1; JOINED; Genomic_DNA.
DR   EMBL; AL031117; CAI43157.1; -; Genomic_DNA.
DR   EMBL; AL117326; CAI43157.1; JOINED; Genomic_DNA.
DR   EMBL; AL357774; CAI43157.1; JOINED; Genomic_DNA.
DR   EMBL; AL031117; CAI43158.1; -; Genomic_DNA.
DR   EMBL; AL117326; CAI43158.1; JOINED; Genomic_DNA.
DR   EMBL; AL357774; CAI43158.1; JOINED; Genomic_DNA.
DR   EMBL; AL117326; CAI43167.1; -; Genomic_DNA.
DR   EMBL; AL031117; CAI43167.1; JOINED; Genomic_DNA.
DR   EMBL; AL357774; CAI43167.1; JOINED; Genomic_DNA.
DR   EMBL; AL117326; CAI43168.1; -; Genomic_DNA.
DR   EMBL; AL031117; CAI43168.1; JOINED; Genomic_DNA.
DR   EMBL; AL357774; CAI43168.1; JOINED; Genomic_DNA.
DR   EMBL; CH471120; EAX02654.1; -; Genomic_DNA.
DR   IPI; IPI00027382; -.
DR   IPI; IPI00410084; -.
DR   RefSeq; NP_001121638.1; -.
DR   RefSeq; NP_001121639.1; -.
DR   RefSeq; NP_001121640.1; -.
DR   RefSeq; NP_001121644.1; -.
DR   RefSeq; NP_001121645.1; -.
DR   RefSeq; NP_002569.1; -.
DR   UniGene; Hs.656789; -.
DR   ProteinModelPortal; O75914; -.
DR   SMR; O75914; 73-156, 262-553.
DR   STRING; O75914; -.
DR   PhosphoSite; O75914; -.
DR   PRIDE; O75914; -.
DR   Ensembl; ENST00000262836; ENSP00000262836; ENSG00000077264.
DR   Ensembl; ENST00000372010; ENSP00000361080; ENSG00000077264.
DR   GeneID; 5063; -.
DR   KEGG; hsa:5063; -.
DR   UCSC; uc004eoz.2; human.
DR   UCSC; uc004epa.2; human.
DR   CTD; 5063; -.
DR   GeneCards; GC0XP110226; -.
DR   H-InvDB; HIX0016993; -.
DR   HGNC; HGNC:8592; PAK3.
DR   MIM; 300142; gene.
DR   MIM; 300558; phenotype.
DR   Orphanet; 777; X-linked nonsyndromic intellectual deficit.
DR   PharmGKB; PA32919; -.
DR   eggNOG; prNOG07467; -.
DR   HOVERGEN; HBG108518; -.
DR   OrthoDB; EOG9N8TQ5; -.
DR   PhylomeDB; O75914; -.
DR   BRENDA; 2.7.11.1; 247.
DR   Pathway_Interaction_DB; p38alphabetapathway; Regulation of p38-alpha and p38-beta.
DR   Reactome; REACT_18266; Axon guidance.
DR   NextBio; 19502; -.
DR   ArrayExpress; O75914; -.
DR   Bgee; O75914; -.
DR   Genevestigator; O75914; -.
DR   GermOnline; ENSG00000077264; Homo sapiens.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0017124; F:SH3 domain binding; IEA:UniProtKB-KW.
DR   GO; GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000095; PAK_box_Rho-bd.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR015750; Ser/Thr_kinase_Pak-rel.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   PANTHER; PTHR22986:SF84; Pak_like; 1.
DR   Pfam; PF00786; PBD; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00285; PBD; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS50108; CRIB; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Allosteric enzyme; Alternative splicing; ATP-binding;
KW   Complete proteome; Developmental protein; Disease mutation; Kinase;
KW   Magnesium; Mental retardation; Metal-binding; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Serine/threonine-protein kinase;
KW   SH3-binding; Transferase.
FT   CHAIN         1    559       Serine/threonine-protein kinase PAK 3.
FT                                /FTId=PRO_0000086469.
FT   DOMAIN       70     83       CRIB.
FT   DOMAIN      283    534       Protein kinase.
FT   NP_BIND     289    297       ATP (By similarity).
FT   REGION       65    150       Autoregulatory region (By similarity).
FT   REGION       65    123       GTPase-binding (By similarity).
FT   REGION       84    282       Linker.
FT   ACT_SITE    402    402       Proton acceptor (By similarity).
FT   BINDING     312    312       ATP (By similarity).
FT   MOD_RES      50     50       Phosphoserine; by autocatalysis (By
FT                                similarity).
FT   MOD_RES     154    154       Phosphoserine; by autocatalysis (By
FT                                similarity).
FT   MOD_RES     436    436       Phosphothreonine; by autocatalysis (By
FT                                similarity).
FT   MOD_RES     535    535       N6-acetyllysine.
FT   VAR_SEQ      93    107       Missing (in isoform 2).
FT                                /FTId=VSP_010242.
FT   VARIANT      67     67       R -> C (in MRX30).
FT                                /FTId=VAR_023825.
FT   VARIANT     380    380       A -> E (in MRX30).
FT                                /FTId=VAR_023826.
FT   VARIANT     440    440       T -> S (in a colorectal adenocarcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_046764.
FT   CONFLICT     32     32       S -> F (in Ref. 2).
FT   CONFLICT     36     36       P -> S (in Ref. 2).
FT   CONFLICT     73     73       P -> S (in Ref. 2).
FT   CONFLICT    106    107       PE -> SL (in Ref. 2).
FT   CONFLICT    123    123       T -> P (in Ref. 2).
FT   CONFLICT    127    130       QKKN -> PEEE (in Ref. 2).
FT   CONFLICT    134    137       VLDV -> CSRC (in Ref. 2).
FT   CONFLICT    146    148       TVN -> PVT (in Ref. 2).
FT   CONFLICT    175    175       T -> P (in Ref. 2).
SQ   SEQUENCE   559 AA;  62310 MW;  BC39AEC6F0A5478B CRC64;
     MSDGLDNEEK PPAPPLRMNS NNRDSSALNH SSKPLPMAPE EKNKKARLRS IFPGGGDKTN
     KKKEKERPEI SLPSDFEHTI HVGFDAVTGE FTPDLYGSQM CPGKLPEGIP EQWARLLQTS
     NITKLEQKKN PQAVLDVLKF YDSKETVNNQ KYMSFTSGDK SAHGYIAAHP SSTKTASEPP
     LAPPVSEEED EEEEEEEDEN EPPPVIAPRP EHTKSIYTRS VVESIASPAV PNKEVTPPSA
     ENANSSTLYR NTDRQRKKSK MTDEEILEKL RSIVSVGDPK KKYTRFEKIG QGASGTVYTA
     LDIATGQEVA IKQMNLQQQP KKELIINEIL VMRENKNPNI VNYLDSYLVG DELWVVMEYL
     AGGSLTDVVT ETCMDEGQIA AVCRECLQAL DFLHSNQVIH RDIKSDNILL GMDGSVKLTD
     FGFCAQITPE QSKRSTMVGT PYWMAPEVVT RKAYGPKVDI WSLGIMAIEM VEGEPPYLNE
     NPLRALYLIA TNGTPELQNP ERLSAVFRDF LNRCLEMDVD RRGSAKELLQ HPFLKLAKPL
     SSLTPLIIAA KEAIKNSSR
//
